References
[1]Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma[J]. N Engl J Med, 2009, 360(10): 973-984.
[2]Bao Z, Guan S, Cheng C, Wu S, Wong SH, Kemeny DM, et al. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway[J]. Am J Respir Crit Care Med, 2009, 179(8): 657-665.
[3]Park SJ, Lee KS, Kim SR, Min KH, Choe YH, Moon H, et al. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation[J]. J Immunol, 2009, 183(5): 32593267.
[4]Huang JJ, Joh JW, Fuentebella J, Patel A, Nguyen T, Seki S, et al. Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of eosinophilic esophagitis[J]. Allergy Asthma Clin Immunol, 2010, 6(1): 25.
[5]Barnes PJ. New therapies for asthma: is there any progress?[J]. Trends Pharmacol Sci, 2010, 31(7): 335-343.
[6]Hamid Q, Tulic M. Immunobiology of asthma[J]. Annu Rev Physiol, 2009, 71: 489-507.
[7]Queto T, Gaspar-Elsas MI, Masid-de-Brito D, Vasconcelos ZF, Ferraris FK, Penido C, et al. Cysteinyl-leukotriene type 1 receptors transduce a critical signal for the up-regulation of eosinophilopoiesis by interleukin-13 and eotaxin in murine bone marrow[J]. J Leukoc Biol, 2010, 87(5): 885-893.
[8]卞涛,赵薇,钱秀,吴艳,崔小川,王红梅,等. 黄芪和地塞米松对哮喘失衡表达转录因子T-bet/GATA-3不同的调节作用[J].中华微生物学和免疫学杂志, 2009, 29(10): 907-913.
[9]金龙腾,张和,李昌崇,张维溪,林立. 香菇多糖对白介素-1β诱导人胚肺成纤维细胞表型转化的影响[J].中国当代儿科杂志, 2011,13(4): 331-335.
[10]Abu-Ghefreh AA, Canatan H, Ezeamuzie CI. In vitro and in vivo anti-inflammatory effects of andrographolide[J]. Int Immunopharmacol, 2009, 9(3): 313-318.
[11]Chandrasekaran CV, Gupta A, Agarwal A. Effect of an extract of Andrographis paniculata leaves on inflammatory and allergic mediators in vitro[J]. J Ethnopharmacol, 2010, 129(2): 203-207.
[12]Dougherty RH, Fahy JV. Acute exacerbations of asthma: epidemiology, biologyand the exacerbation-prone phenotype[J]. Clin Exp Allergy, 2009, 39(2): 193-202.